Taipei, Taiwan

Wen-Tai Li


Average Co-Inventor Count = 5.0

ph-index = 2

Forward Citations = 10(Granted Patents)


Location History:

  • Hsinchu, TW (2004 - 2009)
  • Taipei, TW (2005 - 2010)

Company Filing History:


Years Active: 2004-2010

Loading Chart...
7 patents (USPTO):

Title: The Innovative Contributions of Wen-Tai Li

Introduction

Wen-Tai Li is a prominent inventor based in Taipei, Taiwan. He has made significant contributions to the field of cancer treatment through his innovative research and development of novel compounds. With a total of 7 patents to his name, Li's work is recognized for its potential impact on medical science.

Latest Patents

Among his latest patents, one notable invention is related to "Methods of 1H-indol-3-yl-2-oxoacetamide compounds." This invention focuses on treating cancer or an angiogenesis-related disease using a specific compound formula. Another significant patent involves "Imidazolamino compounds," which are novel compounds that also have applications in cancer treatment. These patents highlight Li's commitment to advancing therapeutic options for patients.

Career Highlights

Wen-Tai Li is affiliated with the National Health Research Institutes, where he conducts his research. His work is characterized by a strong emphasis on developing effective treatments for serious health conditions. Li's innovative approach has garnered attention in the scientific community, contributing to advancements in cancer therapies.

Collaborations

Li has collaborated with notable colleagues, including Chiung-Tong Chen and Der-Ren Hwang. These partnerships have facilitated the exchange of ideas and expertise, further enhancing the quality and impact of their research.

Conclusion

Wen-Tai Li's contributions to the field of cancer treatment through his innovative patents demonstrate his dedication to improving healthcare outcomes. His work continues to inspire future research and development in the medical field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…